working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

Transformative safe effective oral anti-inflammatory

Companies: Abivax SA

HIV: Draining the reservoir; cooling the flame

Companies: Abivax SA

RA Phase 2a opens door to $90bn market

Companies: Abivax SA

ABX464 reduces HIV DNA in latent viral gut reservoir

Companies: Abivax SA

ABX464 likely drug of choice in $18bn IBD market

Companies: Abivax SA

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top